TrialRNS System LGS Feasibility Study
Trial details
- Registry ID
- NCT05339126
- Phase
- Phase 2
NPCE
NeuroPace
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
1Trials in this database
2Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| RNS System LGS Feasibility StudyNCT05339126 | NeuroPace | Phase 2 | Active not recruiting | 2026-11-30Estimated |
Latest recorded trial changes
RNS System LGS Feasibility Study
NCT05339126 · NeuroPace
Primary completion date changed
− Before
31 May 2026
+ After
30 Nov 2026
RNS System LGS Feasibility Study
NCT05339126 · NeuroPace
Recruitment status changed
− Before
Recruiting
+ After
Active not recruiting